Sign inJoin waitlistJoin the waitlist

DH

David Hurd

Professor Emeritus of Hematology and Oncology · Wake Forest University Baptist Medical Center

Credentials: · ·

History

Wake Forest University Baptist Medical Center
Present

Hematology and Medical Oncology
1977–1980
Internal Medicine
1974–1977
Doctor of Medicine
1970–1974

Research

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive…
Journal of Clinical Oncology · 2003 · 1,171 citations
Lenalidomide after stem-cell transplantation for multiple myeloma
New England Journal of Medicine · 2012 · 909 citations
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
New England Journal of Medicine · 1998 · 489 citations

CB
Clara Bloomfield
20 papers
BP
Bruce Peterson
19 papers
PM
Philip Mcglave
16 papers
JC
Julia Cruz
14 papers
Daniel Weisdorf
11 papers
Bayard Powell
10 papers
Ellis Levine
9 papers · 3 as a fellow
Hillard Lazarus
9 papers
Richard Larson
8 papers
CL
Charles Linker
6 papers
Nancy Bartlett
6 papers
Paul Richardson
6 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $41.7K · Wake Forest University Health Sciences
2007–2011
Cancer and Leukemia Group B
National Cancer Institute · U10
Contact PI · $2.6M · Wake Forest University Health Sciences
1979–2009
Detection of Mds Using Fish in Pretransplant Samples
National Cancer Institute · R21
Contact PI · $325.1K · Wake Forest University Health Sciences
2001–2004

Clinical trials

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Principal investigator · Completed · Phase 2
Cristina Gasparetto
2008–2014
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Study chair · Completed
Wake Forest University Health Sciences
2007–2014
Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
Study chair · Completed · Phase 3
Wake Forest University Health Sciences
1996–2003
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer
Study chair · Completed · Phase 2
Wake Forest University Health Sciences
1993–2007